Pfitzner–Moffatt oxidation
Pfitzner–Moffatt Oxidation is a chemical reaction that involves the oxidation of alcohols to aldehydes or ketones using a dimethyl sulfoxide (DMSO) activated by a carbodiimide, typically dicyclohexylcarbodiimide (DCC). This reaction is notable for its mild conditions and broad substrate scope, making it a valuable tool in organic synthesis. The reaction was independently discovered by Hans Pfitzner and James Moffatt in the 1960s.
Mechanism
The Pfitzner–Moffatt oxidation mechanism involves several key steps. Initially, DMSO reacts with the carbodiimide (e.g., DCC) to form an activated DMSO intermediate. This intermediate then reacts with the alcohol substrate to form an alkoxysulfonium ion. Subsequent elimination of this ion leads to the formation of the desired aldehyde or ketone product, along with the release of dimethyl sulfide (DMS) as a byproduct.
Applications
The Pfitzner–Moffatt oxidation has been widely applied in organic synthesis due to its ability to selectively oxidize primary and secondary alcohols under relatively mild conditions. It is particularly useful in the synthesis of complex molecules where sensitive functional groups are present, as the reaction conditions are less likely to cause unwanted side reactions.
Advantages and Limitations
One of the main advantages of the Pfitzner–Moffatt oxidation is its mildness, allowing for the oxidation of sensitive substrates that might be incompatible with more vigorous oxidation conditions. However, the reaction does have some limitations, including the generation of dimethyl sulfide, a malodorous byproduct, and the potential for overoxidation in some cases.
Variants
Several variants of the Pfitzner–Moffatt oxidation have been developed to address its limitations and expand its utility. These include modifications to the activating agent and the use of alternative solvents or additives to improve yield, reduce byproducts, or enable the oxidation of more challenging substrates.
See Also
References
Pfitzner–Moffatt oxidation
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD